» Articles » PMID: 29725697

The Impact of Phosphatases on Proliferative and Survival Signaling in Cancer

Overview
Publisher Springer
Specialty Biology
Date 2018 May 5
PMID 29725697
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The dynamic and stringent coordination of kinase and phosphatase activity controls a myriad of physiologic processes. Aberrations that disrupt the balance of this interplay represent the basis of numerous diseases. For a variety of reasons, early work in this area portrayed kinases as the dominant actors in these signaling events with phosphatases playing a secondary role. In oncology, these efforts led to breakthroughs that have dramatically altered the course of certain diseases and directed vast resources toward the development of additional kinase-targeted therapies. Yet, more recent scientific efforts have demonstrated a prominent and sometimes driving role for phosphatases across numerous malignancies. This maturation of the phosphatase field has brought with it the promise of further therapeutic advances in the field of oncology. In this review, we discuss the role of phosphatases in the regulation of cellular proliferation and survival signaling using the examples of the MAPK and PI3K/AKT pathways, c-Myc and the apoptosis machinery. Emphasis is placed on instances where these signaling networks are perturbed by dysregulation of specific phosphatases to favor growth and persistence of human cancer.

Citing Articles

Low expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer.

Qiu Z, Sigh D, Liu Y, Prasad C, Bean N, Yan C Theranostics. 2024; 14(19):7450-7469.

PMID: 39659585 PMC: 11626944. DOI: 10.7150/thno.96879.


A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of .

Omella J, Cortesi E, Verbinnen I, Remmerie M, Wu H, Cubero F Cancers (Basel). 2023; 15(16).

PMID: 37627221 PMC: 10453342. DOI: 10.3390/cancers15164193.


CSK-mediated signalling by integrins in cancer.

Maldonado H, Leyton L Front Cell Dev Biol. 2023; 11:1214787.

PMID: 37519303 PMC: 10382208. DOI: 10.3389/fcell.2023.1214787.


PME-1 sensitizes glioblastoma cells to oxidative stress-induced cell death by attenuating PP2A-B55α-mediated inactivation of MAPKAPK2-RIPK1 signaling.

Guffens L, Derua R, Janssens V Cell Death Discov. 2023; 9(1):265.

PMID: 37500619 PMC: 10374899. DOI: 10.1038/s41420-023-01572-1.


The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer.

Hsiao K, Ruan S, Chen S, Lai T, Chan R, Zhang Y Cell Commun Signal. 2023; 21(1):172.

PMID: 37430297 PMC: 10332018. DOI: 10.1186/s12964-023-01182-5.


References
1.
Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

2.
Ruvolo P, Clark W, Mumby M, Gao F, May W . A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem. 2002; 277(25):22847-52. DOI: 10.1074/jbc.M201830200. View

3.
Brentnall M, Rodriguez-Menocal L, De Guevara R, Cepero E, Boise L . Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013; 14:32. PMC: 3710246. DOI: 10.1186/1471-2121-14-32. View

4.
Yin Y, Shen W . PTEN: a new guardian of the genome. Oncogene. 2008; 27(41):5443-53. DOI: 10.1038/onc.2008.241. View

5.
Gronda M, Arab S, Iafrate B, Suzuki H, Zanke B . Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol Cell Biol. 2001; 21(20):6851-8. PMC: 99862. DOI: 10.1128/MCB.21.20.6851-6858.2001. View